Unicycive Therapeutics UNCY

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

• 8-KSept. 29, 2026, 7:46 a.m. ETView on SEC.gov

  Departure/appointment of directors or officers · Other events · Financial statements and exhibits

• 8-KSept. 28, 2026, 4:31 p.m. ETView on SEC.gov

  Other events

• SCHEDULE 13G/AAug. 14, 2026, 4:15 p.m. ETView on SEC.gov
• SCHEDULE 13G/AAug. 14, 2026, 4:37 p.m. ETView on SEC.gov
• 8-KAug. 12, 2026, 8:04 a.m. ETView on SEC.gov

  Results of operations and financial condition · Financial statements and exhibits

• 10-QAug. 12, 2026, 6:30 a.m. ETView on SEC.gov
• SCHEDULE 13GJuly 30, 2026, 11:18 a.m. ETView on SEC.gov
• 4/AJuly 28, 2026, 4:15 p.m. ETView on SEC.gov